Coalition seeks funding for HCV/HIV co-infection. Integrating services makes economic, medical sense

Area of Science:

• Public Health
• Infectious Diseases
• Hepatology

Background:

• Hepatitis C virus (HCV) infection affects up to 40% of patients with human immunodeficiency virus (HIV).
• Liver disease is the primary cause of mortality among individuals with acquired immunodeficiency syndrome (AIDS).

Discussion:

• Substantial funding gaps exist for essential hepatitis C screening and treatment programs.
• Current healthcare infrastructures require innovative approaches to integrate HCV screening into established HIV services.

Key Insights:

• Co-infection of HIV and HCV presents a critical public health challenge with significant mortality implications.
• Effective integration of screening protocols is vital for improving patient outcomes.

Outlook:

• Developing and implementing cost-effective, integrated screening strategies is crucial for resource-limited settings.
• Policy interventions and increased funding are necessary to combat the dual epidemic of HIV and HCV.